IP Library Granted Patent US 11,298,053
Granted Patent B2
US 11,298,053 · App. 15/830,415 · Granted Apr 12, 2022

Insulin pump based expert system

Inventor: Michael Blomquist (Blaine, MN)
Assignee: Tandem Diabetes Care, Inc.
A61B5/14532A61B5/4839A61B5/7475A61M5/1723G16H10/20G16H20/17G16H40/63G16H40/67G16H50/20A61B5/7275A61B2560/045A61M2005/14208A61M2205/3561A61M2205/52A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,298,053
App. No.
15/830,415
Granted
Apr 12, 2022
Kind
B2
Abstract

An apparatus comprising a pump configured to deliver insulin, an input configured to receive blood glucose data, a user interface, and a controller communicatively coupled to the pump, the input, and the user interface. The controller includes a blood glucose data module to compare the blood glucose data to a target blood glucose level for an insulin pump user. The controller is configured to present a question related to the blood glucose level via the user interface when the blood glucose level is different than the target blood glucose level, receive a response to the question via the user interface, and present a recommended user action based at least in part on the response. Other devices, systems, and methods are disclosed.

Claims (35)

1. A system comprising:

a pump configured to deliver insulin;

an input configured to receive sensor glucose data representative of a blood glucose level of a user from a continuous glucose monitor via a wireless connection; and

a controller communicatively coupled to the pump and the input, the controller configured to:

monitor the sensor glucose data from the continuous glucose monitor while the pump is delivering a basal rate of insulin to the user;

compare the sensor glucose data to a target low glucose level;

determine a rate of change of the blood glucose level of the user from the sensor glucose data;

generally continuously monitor the rate of change;

determine based on the generally continuous monitoring of the rate of change that, although the sensor glucose data does not indicate that the glucose level of the user is below the target low glucose level that the rate of change indicates that the glucose level of the user is at risk of going below the target low glucose level due to the basal rate of insulin being delivered to the user;

provide a message on a user interface relating to the risk of going below the target low glucose level; and

reducing a rate of basal insulin being delivered to the user in response to the risk of going below the target low glucose level.

2. The system of claim 1 , wherein the controller providing a message relating to the risk of going below the target low glucose level includes providing a message relating to a corrective action responsive to the risk of going below the target low glucose level.

3. The system of claim 2 , wherein the corrective action is a recommendation to ingest carbohydrates.

4. The system of claim 1 , wherein the controller is further configured to implement a corrective action in response to the risk of going below the target low glucose level.

5. The system of claim 4 , wherein the implemented corrective action is a recommendation to ingest carbohydrates.

6. The system of claim 4 , wherein the controller is configured to determine that, although the sensor glucose data does not indicate that the glucose level of the user is below the target low glucose level that the rate of change indicates that the glucose level of the user is at risk of going below the target low glucose level by applying one or more rules to the rate of change.

7. A system comprising:

a pump configured to deliver insulin;

an input configured to receive sensor glucose data representative of a blood glucose level of a user from a continuous glucose monitor via a wireless connection; and

a controller communicatively coupled to the pump and the input, the controller configured to:

monitor the sensor glucose data from the continuous glucose monitor while the pump is delivering a basal rate of insulin to the user;

compare the sensor glucose data to a target low glucose level;

determine a rate of change of the blood glucose level of the user from the sensor glucose data;

generally continuously monitor the rate of change;

determine, based on the generally continuous monitoring of the rate of change that, although the sensor glucose data does not indicate that the glucose level of the user is below the target low glucose level that the rate of change indicates that the glucose level of the user is at risk of going below the target low glucose level due to the basal rate of insulin being delivered to the user; and

implement a corrective action in response to the risk of going below the target low glucose level, including reducing a basal rate of insulin being delivered to the user.

8. The system of claim 7 , wherein the implemented corrective action is a recommendation to ingest carbohydrates.

9. The system of claim 7 , wherein the controller is further configured to provide a message on a user interface relating to the risk of going below the target low glucose level.

10. The system of claim 9 , wherein the controller providing a message relating to the risk of going below the target low glucose level includes providing a message relating to the corrective action.

11. The system of claim 10 , wherein the corrective action is a recommendation to ingest carbohydrates.

12. The system of claim 7 , wherein the controller is configured to determine that, although the sensor glucose data does not indicate that the glucose level of the user is below the target low glucose level that the rate of change indicates that the glucose level of the user is at risk of going below the target low glucose level by applying one or more rules to the rate of change.

13. The system of claim 1 , wherein the controller is configured to reduce the basal rate of insulin being delivered to the user in response to a manual instruction from the user to reduce the basal rate of insulin.

14. The system of claim 13 , where the controller is further configured to present a recommendation to reduce the basal rate of insulin to the user and to reduce the basal rate of insulin if the user accepts the recommendation.

15. The system of claim 7 , wherein the controller is configured to reduce the basal rate of insulin being delivered to the user in response to a manual instruction from the user to reduce the basal rate of insulin.

16. The system of claim 15 , where the controller is further configured to present a recommendation to reduce the basal rate of insulin to the user and to reduce the basal rate of insulin if the user accepts the recommendation.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2024
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: TANDEM DIABETES CARE, INC.
Reel/Frame 066880/0918 →
SECURITY INTEREST Recorded May 25, 2022
From: TANDEM DIABETES CARE, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060179/0100 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2017
From: SMITHS MEDICAL ASD, INC.
To: TANDEM DIABETES CARE, INC.
Reel/Frame 044353/0465 →
MERGER Recorded Dec 8, 2017
From: SMITHS MEDICAL MD, INC.
To: SMITHS MEDICAL ASD, INC.
Reel/Frame 044342/0961 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2017
From: BLOMQUIST, MICHAEL
To: SMITHS MEDICAL MD, INC.
Reel/Frame 044287/0511 →
Continuity (4)
Continuation 14187414 · Feb 24, 2014
Continuation 13465570 · May 7, 2012
Division 11755480 · May 30, 2007
Related Publication 20180092578A1 · Apr 5, 2018
Cited By (1)
US 12,431,104